Taysha Gene Therapies, Inc. (TSHA) Financials
TSHA Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 172.7 million | 97.8 million |
| 2023-09-30 | 195.8 million | 244.9 million |
| 2023-06-30 | 81.5 million | 118.7 million |
| 2023-03-31 | 101.6 million | 116.5 million |
TSHA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -16.1 million | 2.0 million |
| 2023-09-30 | -21.4 million | 2.0 million |
| 2023-06-30 | -18.7 million | 2.2 million |
| 2023-03-31 | -24.1 million | 1.7 million |
TSHA Net Income
No data available :(
TSHA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | - | - | 20.6 million |
| 2023-09-30 | 164.3 million | - | 20.6 million |
| 2023-06-30 | 45.1 million | 38.4 million | 21.2 million |
| 2023-03-31 | 63.4 million | 38.2 million | 21.7 million |
TSHA Shares Outstanding
TSHA Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 17000 | 12.7 million | 6.7 million | - |
| 2023-09-30 | 3.5 million | 11.8 million | 8.6 million | - |
| 2023-06-30 | 48000 | 19.8 million | 6.0 million | - |
| 2023-03-31 | 3.9 million | 12.5 million | 8.8 million | - |
TSHA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | 3.6 million | - |
| 2023-09-30 | 4.7 million | 331000 |
| 2023-06-30 | 2.4 million | 703000 |
| 2023-03-31 | 4.7 million | 631000 |
TSHA
Price: $2.39
52 week price:
Earnings Per Share: -0.96 USD
P/E Ratio: -0.51
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 1.1 million
Market Capitalization: 501.2 million